Page last updated: 2024-08-22

cladribine and Lymphocytosis

cladribine has been researched along with Lymphocytosis in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (33.33)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (66.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Campo, E; Martínez-Trillos, A; Matutes, E	1
Chavda, SJ; Dearden, C	1
Bassous, L; Berrebi, A; Klepfish, A; Shtalrid, M; Shvidel, L; Vorst, E	1

Reviews

1 review(s) available for cladribine and Lymphocytosis

Article	Year
Hairy cell leukaemia-variant: Disease features and treatment. Best practice & research. Clinical haematology, 2015, Volume: 28, Issue:4 Topics: Aged; Antigens, CD; Antineoplastic Agents; B-Lymphocytes; Bone Marrow; Chromosome Deletion; Chromosomes, Human, Pair 17; Cladribine; Humans; Immunoglobulin Heavy Chains; Leukemia, Hairy Cell; Lymphocytosis; Male; MAP Kinase Kinase 1; Mutation; Rituximab; Spleen; Splenomegaly; Survival Analysis; Tumor Suppressor Protein p53	2015

Article

Year

Hairy cell leukaemia-variant: Disease features and treatment.

Best practice & research. Clinical haematology, 2015, Volume: 28, Issue:4

Topics: Aged; Antigens, CD; Antineoplastic Agents; B-Lymphocytes; Bone Marrow; Chromosome Deletion; Chromosomes, Human, Pair 17; Cladribine; Humans; Immunoglobulin Heavy Chains; Leukemia, Hairy Cell; Lymphocytosis; Male; MAP Kinase Kinase 1; Mutation; Rituximab; Spleen; Splenomegaly; Survival Analysis; Tumor Suppressor Protein p53

2015

Other Studies

2 other study(ies) available for cladribine and Lymphocytosis

Article	Year
Interesting case of lymphocytosis and splenomegaly. BMJ (Clinical research ed.), 2016, Mar-03, Volume: 352 Topics: Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cladribine; Diagnosis, Differential; Female; Humans; Leukemia, Hairy Cell; Lymphocytosis; Rituximab; Splenomegaly; Treatment Outcome	2016
B-cell prolymphocytic leukemia: a survey of 35 patients emphasizing heterogeneity, prognostic factors and evidence for a group with an indolent course. Leukemia & lymphoma, 1999, Volume: 33, Issue:1-2 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cladribine; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Immunophenotyping; Leukemia, B-Cell; Leukemia, Prolymphocytic; Lymphocytosis; Male; Middle Aged; Prognosis; Retrospective Studies; Splenomegaly; Survival Rate	1999

Article

Year

Interesting case of lymphocytosis and splenomegaly.

BMJ (Clinical research ed.), 2016, Mar-03, Volume: 352

Topics: Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cladribine; Diagnosis, Differential; Female; Humans; Leukemia, Hairy Cell; Lymphocytosis; Rituximab; Splenomegaly; Treatment Outcome

2016

B-cell prolymphocytic leukemia: a survey of 35 patients emphasizing heterogeneity, prognostic factors and evidence for a group with an indolent course.

Leukemia & lymphoma, 1999, Volume: 33, Issue:1-2

Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cladribine; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Immunophenotyping; Leukemia, B-Cell; Leukemia, Prolymphocytic; Lymphocytosis; Male; Middle Aged; Prognosis; Retrospective Studies; Splenomegaly; Survival Rate

1999